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ox2u-GIobuIin Nephropathy: Review ofthe
Cellular and Molecular Mechanisms lnvolved
and Their Implicaions for Human Risk
Assessment
by James A. Swenberg
Thispaper reviewswhat is knownabout the induction of(x.u-globulin nephropathy and carcinogenesis. This
unique male-rat-specific disease is associated with exposure to an ever-increasing number ofchemicals. The
processes leading to nephropathy and renal cancer are among the best-understood mechanisms for non-
genotoxicchemicals and strongly support that it is a male-rat-specific process that is not relevant for human
risk assessment. Nevertheless, the data available for individual chemicals vary greatly. This necessitates a
case-by-case analysis of the available data when determining the relevance for humans of this chemically
induced renal disease in male rats.
Introduction
After the discovery thatunleaded gasoline (UG) caused
kidney tumors in male rats but not in female rats oreither
sex of mice, a series of studies was undertaken to under-
stand this sex- and species-specific disease. Investigations
by Halder et al. demonstrated the formation of protein
droplet nephropathy by a series of branched aliphatic
hydrocarbons (1,2). One of the most potent hydrocarbons
causing this disease wAas 2,2,4-trimethylpentane (TMP),
an important component of gasoline. The suggestion that
hydrocarbon nephropathy might be related to the male-
rat-specific protein, "2,,-globulin (X2,,) was first made by
Alden, who identified ox92 as the accumulating protein in
male rats exposed to decatin and hypothesized that a
similarphenomenon might occurwith otherhydrocarbons
(3,4). Since these early studies, many additional chemicals
have been shown to cause a2xz nephropathy in male rats.
None ofthese have caused asimilar nephropathy in female
rats or either sex of any other species (5-7). Thus, 2>,,
nephropathy appears to represent a sex- and species-
specific disease.
u2Xu Nephropathy is characterized by the accumulation
of protein droplets in the P2 segment of the proximal
tubule, subsequent single cell necrosis, the formation of
granular casts at the junction of the proximal tubule and
the thin loop of Henle, and the presence of regenerative
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tubules. With chronic exposure, there is a progression of
these lesions, the formation oflinear mineralization in the
renalmedulla, and an exacerbation ofchronic progressive
nephropathy, the spontaneous nephropathy ofaging rats.
Chronic exposure ofmale rats to UG and numerous other
nongenotoxic chemicals also led to the formation of
exposure-related increases in renal tumors. The incidence
of tubular neoplasms of the kidney induced by agents
causing %,,1 nephropathy ranged from 0 to 26%. This is
markedly different from the induction ofrenal tumors by
known genotoxic agents, which frequently reaches 100%
(8).Thechemicalsknowntocausethis°t2, nephropathyare
listed in Table 1.
The protein 2tix is a well-characterized, low moleculai
weightprotein of18,700 D thatis synthesizedinthe liverof
male rats under androgenic control, secreted into the
plasma, and freely filtered by the glomerulus (9,10).
Approximately half of the (X2u present in the glomerular
filtrate is resorbed by the P2 segment of the proximal
tubule ofthe nephron, and the other halfis excreted in the
urine (11,12). Tubular resorption of U2,, occurs via
endocytosis. The endosomes then fuse with primary lyso-
somes, where the protein undergoes hydrolytic digestion.
Whereaslarge amounts ofprotein arefoundin theurine
ofmalerats,U2uisfoundintheurineoffemaleand sexually
immature rats at concentrations that are less than 1/100
that found in young adult males (13,14). Hepatic synthesis
accounts for most of the o2u in male rats, with synthesis
beginning at the onset of sexual maturity and increasing
to 20 weeks ofage, afterwhich it plateaus and then begins
to decline with increasing age (15). Female rats do notJ. A. SWEABERG
Table 1. Data sets for chemicals causing ox,u-globulin nephropathy (7).
Pirotein Incrieased Cell Initiation/
Substance/chemical droplets Qx.,, I Binding plroliferation promotion
d-Limonene + + + + +
Unleaded gasoline + + + + +
2,2,4-nTimethylpentane + + + + +
1,4-Dichloirobenzene + + + + NR
Isophorone + + + + NR
3,5,5-Trimethyl hexanoic acid derivatives + + + NR NR
Decalin + + NR +± NR
Tetrachloroethvlene + + NR + NR
Pentachloroethane + + NR + NR
CIO0-C,2 isoparaffinic solvent
(saturated aliphatic hydrocarbons) + + NR NR NR
Lindane + + NR NR NR
BW540C + + NR NR NR
BW58C + + NR NR NR
Levamisole + + NR NR NR
Gabapentin + + NR NR NR
Tridecyl acetate + + NR NR NR
Isopropylcyclohexane + + NR NR NR
JP-5 jet fuel (mixed distillate hydrocarbons) + NR NR NR NR
JP-4 jet fuel (mixed distillate hydrocarbons) + NR NR NR NR
Diesel, fuel maline + NR NR NR NR
JP-1O synthetic jet fuel (exohexahydro-4,7-
methanoindan) + NR NR NR NR
RJ-5 synthetic jet fuel (hydrogenated dimers
ofnorbornadiene) + NR NR NR NR
JP-7 distillate jet fuel + NR NR NR NR
JP-TS dlistillate jet fuel + NR NR NR NR
Stod(daid solvent + NR NR NR NR
Tetralin + NR NR NR NR
Hexachloiroethane + NR NR NR NR
Dimethyl methylphosphonate + NR NR NR NR
Methyl isobutyl ketone + NR NR NR NR
Methyl isoamyl ketone + NR NR NR NR
Diisobutyl ketone + NR NR NR NR
1,3,6-Tricyanohexane + NR NR NR NR
NR, not reported.
'Based on cell counts from urine.
synthesize Ot2Uin the liverbut do synthesize small amounts
of the protein in the salivary gland.
Cellular and Molecular Mechanisms
of t2u Nephropathy
An early hypothesis for an association between ox21 and
UG in the induction of the male-rat-specific nephropathy
and associated carcinogenicity was that TMP and related
hydrocarbons were being metabolized to their respective
aldehydes, which formed a Schiffs base and covalently
bound to U2ii (16). Whole-body autoradiographs after
administration of [14C] TMP demonstrated selective
retention of radioactivity in the renal cortex of male but
not female rats (16). Likewise, kidney cytosol contained
prominent amounts of labeled TMP that exhibited a
supralinear dose response, while no accumulation was
evident in female kidney or in liver of either sex (16).
Subsequent experiments demonstrated that the observed
binding was not covalent, however (17). If kidney cytosol
from male rats administered [14C] TMP was separated by
G75 Sephadex chromatography, the radioactivity coeluted
with the low molecular weight protein fraction and free
metabolites. Ifthe cytosol was first dialyzed against phos-
phate buffer, radioactivity only coeluted with the low
molecular weight proteins. When the protein denaturing
detergent, sodium dodecyl sulfate, was added to the
dialysis buffer, the radioactivity associated with the low
molecular weight protein fraction was lost. These experi-
ments demonstrated that the binding between the low
molecular protein fractions and TMP was reversible, not
covalent (17). Immunoassay of the same low molecular
weight protein chromatography fractions demonstrated
the presence of a2u. These fractions were collected,
extracted with acidified ethyl acetate, and analyzed bygas
chromatography-mass spectrometry toidentifythebound
material. The reversibly bound metabolite of TMP was
identified as 2,4,4-trimethyl-2-pentanol (TMPOH). Subse-
quentexperiments exposedmale F344 ratsto50ppmTMP
or300ppmUG and demonstrated thatTMPOHwasbound
to 0L2u (18).
Reversible binding to x2u has been demonstrated for at
least 13 chemicals in in vitro or in vivo studies (17,19-21).
Even though the agents fall into rather diverse chemical
classes, molecular modeling studies have demonstrated
strong structure-activity relationships (22). Active chemi-
cals fit deeply into a hydrophobic pocket of o2uL. When
hydrogen bonding between the chemical and protein can
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occur, the digestibility of (X2U by proteases is inhibited,
leading to accumulation ofthe male-rat-specific protein in
lysosomes ofthe P2 segment ofthe nephron (23).
The accumulation of t2u iS cytotoxic and results in
single-cell necrosis (24-26). The exfoliated renal epi-
thelium, which represents the nidus for granular cast
formation, is restored by compensatory cell proliferation.
This increase in cell proliferation is localized in the P2
segment ofthe nephron and to amuch lesser extent in the
P3 segment (25,27,28). Increased cell proliferation can be
readily demonstrated using pulse (27) or continuous (25-
26,28) administration of [3H]-thymidine or bromodeox-
yuridine, canbe detected as early as 3 days after exposure
to t2u-inducing agents, and has been demonstrated to
remain elevated through at least 50 weeks of exposure to
UG (25). The increase in proliferation is dose related, with
maximum tolerated doses (MTD) resulting in 5- to 12-fold
greater numbers of labeled cells (25,28). Clear, no-effect
doses have been demonstrated (25,27,28). Ofgreat impor-
tance is the demonstration thatkidneys offemale rats that
have been identically exposed to UG have no increase in
cell proliferation (25). While this strongly suggests that
the increase in cell proliferation requires the presence of
large amounts of at2U, a recent study comparing cell pro-
liferation in d-limonene exposed F344 versus NBR male
rats has shown thattheprotein is absolutelyrequired (26).
The NBR rat is the only identified strain of rat that does
not synthesize the androgen-dependent form of u2u (29).
Whereas the F344 rats exposed to d-limonene exhibited a
5-fold increase in cell proliferation after 5 or 30 weeks of
exposure to 150 mg/kg/day, NBR rats were unaffected
(26). Both strains metabolized d-limonene to the 1,2-oxide,
the nonmutagenic metabolite that reversibly binds to t2u
(21,26,30). The increase in cell proliferation associated
with Ot2u nephropathy is reversible. After exposures of up
to 3 weeks to TMP or UG, proliferation returns to control
rates within 1 week after cessation of exposure (25).
Longer-term exposures resultin aslowerreturn tocontrol
rates. Morphologic evidence of regenerative tubules can
stillbeidentified 4weeks aftersubchronic exposure ceases
(1,2).
This sustained increase in cellproliferation is capable of
promoting spontaneously initiated or chemically initiated
cells of the proximal tubule to form preneoplastic and
neoplastic lesions (26,31). The promoting activity is totally
dependent on the presence of a2,. When F344 rats were
exposed to UG or TMP in an initiation-promotion study,
concentration-related increases in preneoplastic and neo-
plastic renal lesions were evident in males initiated with
ethylhydroxyethylnitrosamine (EHEN) and promoted
with UG or TMP (31). No increases occurred in females.
The promoting activity paralleled increases in cell pro-
liferation (25). When NBR rats were initiated with EHEN
and promoted with d-limonene, no increase in atypical
tubules, atypical hyperplasia, or renal adenomas occurred
(26). In contrast, F344 rats promoted with d-limonene
developed increased numbers of atypical tubules and
atypical hyperplasia, while F344 rats initiated with
EHEN and promoted with d-limonene developed
increased numbers of atypical tubules, atypical hyper-
plasias, andrenaladenomas (26). Promotionofpreneoplas-
tic or neoplastic lesions only occurred in groups that also
exhibited increased cell proliferation. An important obser-
vation from this study was the presence of occasional
preneoplastic lesions in the kidneys ofcontrol rats ofboth
strains, as these lesions are thought to represent precur-
sors ofspontaneous kidney tumors. The incidence ofthese
lesions was increased by exposure to EHEN in both
strains and by exposure to d-limonene alone in male F344
rats. These data strongly suggest that agents that cause
t2unephropathy, such as UG, induce renal tumors in male
rats through sustained increases in cell proliferation. The
higher rate of cell proliferation decreases the amount of
time available to repair DNA damage, increasing the
probabilityofmutationsleadingto spontaneouslyinitiated
renal epithelial cells and promoting clonal expansion of
such cells, thereby increasing the probability ofneoplasia
(32,33).
Additional evidence forthe sexand species specificity of
this syndrome comes from studies on levamisole.
Levamisole, a drug used as an antihelminthic in cancer
chemotherapy and in the treatment of rheumatoid
arthritis in humans, causes a2u nephropathy in male rats
(34). No increase in urinary N-acetyl 3-glucosaminidase,
an indicator of nephrotoxicity, was present in patients
receiving 150 mg levamisole per day for 26 weeks (35).
Levamisole has notbeen studied yet forcarcinogenicityin
animals or humans.
Several ofthechemicals thatinduceoL2u-related malerat
kidney tumors also cause tumors in mouse liver. 1,4-
Dichlorobenzene, isophorone, pentachloroethane, tetra-
chloroethylene, and UG represent such examples (36-41).
The mechanism responsible for the induction of liver
tumors is not definitively known at this time. Marked
decreases in uterine cystic hyperplasia and uterine involu-
tion were apparent in the high-dose group of the UG
mouse carcinogenicity bioassay but not in the middle- or
low-dose groups (42). This suggests that the hormonal
status ofthe high-dose female mice was affected by expo-
sure to UG. Itiswell documented that either castration or
administration of testosterone to female mice increases
theincidence ofhepatic neoplasia (43). Thus, theincreased
incidence ofhepatic tumors inthe UGmousebioassaymay
have been due to a secondary mechanism that does not
extrapolate to low exposures. Additional research will be
necessary to further delineate therole ofhormonal altera-
tion for UG and the other chemicals known to cause t2u
nephropathy and female mouse liver tumors.
Not all agents that induce °t2u nephropathy have
resultedinanincreasedincidenceofkidneytumorsinmale
rats. In some cases, this has been due to an inadequate
length ofexposure. Forexample, a series ofhydrocarbons
was evaluated in rats exposed for 90 days and held for an
additional 19 months (44,45). None of the hydrocarbons
causedincreases inrenal tumors.When ratswereexposed
tothe samehydrocarbons for 1 ormoreyears,tumorswere
induced in the kidneys ofmale rats. An antiepileptic agent
has recently been shown to induce a2u nephropathy in
Wistar rats, but it did not induce renal neoplasia (46).
Although a2u was demonstrated immunohistochemically,
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no information on binding, cell proliferation, or initiation!
promotion is available. The incidence of renal tumors
induced bythe(.2.mechanismismuch lower(0-26%)than
can be achieved by genotoxic renal carcinogens admin-
istered attheirmaximum tolerateddose (8). Furthermore,
the extent of mechanistic research available for different
agents varies markedly (Table 1). Thus, although the
weight of evidence available for this class of agents sup-
porting this sex- and species-specific mechanism is very
strong, determination ofthe relevance ofthis mechanism
for a specific chemical's carcinogenic activity requires a
case-by-case analysis.
Species Differences in Urinary Protein
Having established that the presence of CX2u is manda-
tory for the formation of male-rat kidney tumors after
treatment with a2 nephropathy-inducing agents, the
question arises whether extrapolation of such carcino-
genicity data to other species, including humans, is war-
ranted. Most compounds that are carcinogenic in animals
aregenerallyassumed topose somnerisktohumans. Inthe
case of ot2, nephropathy-inducing agents, however, the
carcinogenic mechanism is clerly associated with the
presence of a specific urinary protein (%u) not found in
humans or any other species. Several proteins sharing
some amino acid sequenee homology with %2u have been
identified in the serumand urineofvarious species, includ-
ing humans (47-50). The presence of these partially
homologous proteins in humans raised coneern as to the
possibleinteraction oftheselowniolecularweightproteins
with U2u nephropathy-inducing agents, th-us questioning
themale-rat specificity of(x2, nephropathy. Assumingthat
ahomologous protein reversiblybindsthepreviously men-
tioned chemicals, the protein needs tobeexcreted into the
plasma in large amounts, freelyfiltered bytheglomerulus,
readily reabsorbed in the proximal tubules, and cata-
bolized in the lysosomes of the proximal tubule epithelial
cells at a slower rate than normalupon binding one ofthe
chemicals in order to induce similar lesions to 02U
nephropathy.
Based on estimated daily average urine production and
bodyweights ofrats and humai-s, Olsanetal. (51) showed
that rats excrete approximately 90 times more total pro-
tein than humans. Ofthe total protein excreted, the pre-
dominant fraction in rats consisted of low molecular
weight proteins (18 kD), whereas a predominance ofhigh
molecular weight proteins (66 kD) was found in humans.
The small amount of low molecular weight proteins
excreted by male humans was identified as -1-acid
glycoprotein, ol-microglobulin, myoglobin, and 02-
microglobulin. Of these four proteins, only o1-acid
glycoprotein and xl-microglobulin share amino acid
sequence homology with o2u (47,48,50). al-Acid glyeopro-
tein (AGP) andcol-microglobulin (AMG) are synthesized in
the liver ofrats and humans (50,52-54), have beenpurified
from the urine ofrats and humans, as well as the urine of
rabbits and guinea pigs in the case ofAMG (48,54), and,
thus, permit a direct comparison with o2u-
If AGP and AMG reversibly bind 2u nephropathy-
inducingchemicals and/or theirmetaboliteswith the same
affinity as o2u, then one would expect that female rats,
male NBR rats, rabbits, and guinea pigs would also
develop renal disease after treatment with these chemi-
cals.However,male NBRrats,femalerats,andguineapigs
do not accumulate protein in the renal cortex after treat-
mentwith 2u nephropathy-inducing agents and,thus, are
refractory to this disease (5,27,55,56-60) Furthermore,
several members ofthe superfamily, including AGP, have
been shown not to bind a2%-inducing metabolites (61) In
addition, mice, which excrete comparable amounts of the
low molecular weight mouse urinary protein (MUP) hav-
ing the greatest amino acid sequence homology to a2u
(approximately90%)(6), donotdeveloptheprotein-related
nephropathy orrenaltumorsafterchronicexposuretoot2U
nephropathy inducing agents (36,39-41,62-43). Lehman-
McKeeman et al. demonstrated that the lack of respon-
siveness ofthe mouse is due to a lack ofcX2u nephropathy-
inducingmetabolites to bind to MUP and thelack ofMUP
resorption by mouse renal tubules (64)
Recently, asex-linked humanprotein ofsimilarsizewas
identifiedin urinefrompatientswith renal disease (65,66).
This protein has been named urine protein 1 and hasbeen
called thehuman equivalent ofat2u(65).This reference has
led toconsiderable confusion and miscitation. Jackson and
Turner (67) purified and partiallysequenced human urine
protein 1 and determined that it is related to rabbit uter-
oglobin, nota-2u. Urine protein 1 doesnotbind d-limonene-
1,2-oxideor 2,4,4-trimethyl-2-pentanol, two metabolites of
chemicals that bind X a (61). Urine protein 1 also is
present in human urineatconcentrations four to fiveorders
ofmagitude less that that ofa2u in male rat urine (7).
Conclusions
Adetailed understanding ofthemechanisms involved in
ot2u nephropathy and renalcareinogenesis has been eluci-
datedbyinvestigating severalchemicalsinvarious animal,
biochemical, and molecular modeling systems. All of the
experimental data are consistent with the hypothesis that
reversible bindingofchemicals ortheirmetabolites to this
abundant male-rat-specific protein is causally related to
the induction of disease. Our present understanding of
this disease process strongly suggests that it is unlikely
that nongeno-toxic chemicals that have been shown to only
inducerenaltumorsinmaleratsviathismechanismposea
carcinogenic risk to humans.
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